Skip to main content
ConductScienceScienceDex

Mark A Kay

From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.

FY2024 NIH rank #3,353
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1876509Search this ID in NIH RePORTER
ORCID iD
https://orcid.org/0000-0002-2799-2615Verified identifier for this researcher
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Pediatrics

NIH Funding · FY2024

Linked Award Amount
$2.6M
Full award amounts, FY2024
Award Records
4
Records listing this PI
Award-Linked Rank
#3,353
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Mark A Kay. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Mark A Kay as a PI. Multi-PI records show the full award amount for context.

  • 2R01HL064274-22A1R01Contact PI
    Hepatic gene transfer for the treatment of hemophilia B and other genetic diseases
    Stanford University · Pediatrics (NIH department code)
    $701.3K
    award amount
  • 5R37AI071068-19R37Contact PI
    Acute/chronic limitations to transcriptional RNAi therapies for infectious and other liver diseases
    Stanford University · Pediatrics (NIH department code)
    $699.7K
    award amount
  • 5R01AI116698-10R01Contact PI
    AAV capsid engineering for enhancing gene transfer
    Stanford University · Pediatrics (NIH department code)
    $696.2K
    award amount
  • 5R01CA277059-02R01Contact PI
    3' tsRNAs: biologic function and pre-clinical targeting for treating human disease
    Stanford University · Pediatrics (NIH department code)
    $518.2K
    award amount

Award organization

Organizations that administered FY2024 awards listing Mark A Kay as a PI.

FY2024 award administered by Stanford University (CA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Stanford University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #3353
  6. 2024
    Entered Top 25% Nationally
    Ranked #3353
  7. 2025
    $5M Cumulative Funding
  8. 2025
    R01 Grant Holder

Explore further

Find collaborators for Mark A Kay

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →